Donor CYP3A5 Expression Decreases Renal Transplantation Outcomes in White Renal Transplant Recipients

BACKGROUND: After renal transplantation, immunosuppressants should be administered to prevent organ rejection and prolong graft survival. One of them is tacrolimus, which is metabolized by the CYP3A enzyme family. The variability of the CYP3A5 gene in renal transplant recipients has been previously...

Descripción completa

Detalles Bibliográficos
Autores principales: Warzyszyńska, Karola, Zawistowski, Michał, Karpeta, Edyta, Jałbrzykowska, Agnieszka, Kosieradzki, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339223/
https://www.ncbi.nlm.nih.gov/pubmed/35879888
http://dx.doi.org/10.12659/AOT.936276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339223/
https://www.ncbi.nlm.nih.gov/pubmed/35879888
http://dx.doi.org/10.12659/AOT.936276

Ejemplares similares